(S)-2-(Piperazin-2-yl-acetonitrile dihydrochloride CAS: 2158301-19-8

CAS NO: 2158301-19-8
(S)-2-(Piperazin-2-yl-acetonitrile dihydrochloride
Chemical Name: (S)-2-(piperazin-2-yl)acetonitrile dihydrochloride
Molecular Formula: C6H13Cl2N3
Formula Weight: 198.09352
CAS No.: 2158301-19-8
Description Review
Description

(S)-2-(Piperazin-2-yl-acetonitrile dihydrochloride) is a chemical compound that has recently gained attention for its potential therapeutic properties. It falls under the category of piperazine derivatives and is primarily used in the pharmaceutical industry as an intermediate for the synthesis of various drugs. This article aims to provide a comprehensive overview of this product, including its chemical name, molecular formula, CAS No, health benefits, potential effects, product mechanism, safety, side effects, dosing information, and a conclusion.

Chemical Name

The chemical name of (S)-2-(Piperazin-2-yl-acetonitrile dihydrochloride) is (2S)-2-(2-cyanopyrrolidin-1-yl) ethyl piperazine dihydrochloride. It is also known by its trade names such as N-[2-(Piperazin-2-yl)ethyl]propanenitrile hydrochloride and 2-(2-Pyrolidin-1-yl)ethylacetonitrile hydrochloride.

Molecular Formula

The molecular formula of (S)-2-(Piperazin-2-yl-acetonitrile dihydrochloride) is C10H17Cl2N3.

Formula Weight

The formula weight of (S)-2-(Piperazin-2-yl-acetonitrile dihydrochloride) is 250.18 g/mol.

CAS No

The CAS No of (S)-2-(Piperazin-2-yl-acetonitrile dihydrochloride) is 2158301-19-8.

Top Ten Keywords from Google and Synonyms

  1. Piperazin-2-yl-acetonitrile dihydrochloride
  2. N-[2-(Piperazin-2-yl)ethyl]propanenitrile hydrochloride
  3. 2-(2-Pyrolidin-1-yl)ethylacetonitrile hydrochloride
  4. Intermediate for drugs
  5. Pharmaceutical industry
  6. Chemical synthesis
  7. Piperazine derivatives
  8. Health benefits
  9. Potential effects
  10. Safety

Health Benefits of This Product

(S)-2-(Piperazin-2-yl-acetonitrile dihydrochloride) is primarily used as an intermediate in the synthesis of various drugs. Hence, its health benefits are mainly associated with the drugs it helps produce rather than any direct effects of its own. For instance, some studies have shown that certain piperazine derivatives exhibit antipsychotic properties and may be effective in treating conditions like schizophrenia and bipolar disorder.

Potential Effects

As mentioned earlier, the potential effects of (S)-2-(Piperazin-2-yl-acetonitrile dihydrochloride) are mainly related to the drugs it helps synthesize. Some of these effects include:

  1. Antipsychotic: Some piperazine derivatives, when used in conjunction with other drugs or therapies, have been shown to alleviate symptoms of schizophrenia, bipolar disorder, and other psychiatric conditions.

  2. Anti-inflammatory: Certain piperazine derivatives possess anti-inflammatory properties and may be effective in treating conditions like asthma, arthritis, and other inflammation-related disorders.

  3. Antifungal: A few piperazine derivatives have exhibited promising antifungal activity against various fungal strains and may be useful in developing new antifungal medications.

Product Mechanism

The precise mechanism of action of (S)-2-(Piperazin-2-yl-acetonitrile dihydrochloride) is not fully understood. However, it is believed to function as an intermediate in the synthesis of various drugs, which exert their effects via different mechanisms of action depending on the drug's specific targets.

Safety

(S)-2-(Piperazin-2-yl-acetonitrile dihydrochloride) is considered safe for use in the pharmaceutical industry as an intermediate. However, it is crucial to handle this compound with care as it can be hazardous if mishandled. Direct contact with the skin, eyes, or mucous membranes should be avoided, and appropriate protective gear should be worn when handling it.

Side Effects

Since (S)-2-(Piperazin-2-yl-acetonitrile dihydrochloride) is primarily used as an intermediate in drug synthesis, any side effects associated with its use would likely arise from the drugs it helps produce rather than from the compound itself.

Dosing Information

There is no established dosing information available for (S)-2-(Piperazin-2-yl-acetonitrile dihydrochloride) since it is primarily used as an intermediate in drug synthesis.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code